Position history for Epoch Investment Partners, Inc.'s holdings in REGENERON PHARMACEUTICALS
Epoch Investment Partners, Inc. holds 238,725 shares of REGN (REGENERON PHARMACEUTICALS), worth $184.4M as of 2026-Q1. The position was decreased (-15.2% shares). REGN represents 1.1% of Epoch Investment Partners, Inc.'s portfolio.
Current Value
$184.4M
Current Shares
238,725
Total Value Change
+$12.8M
Total Shares Change
+75,429
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 238,725 |
-15.2% |
| $184.4M |
| 1.1% |
| $766.66 |
0 |
| 2025-Q4 | Increased | 281,335 | +8.6% | $217.2M | 1.2% | $773.94 | 52 |
| 2025-Q3 | Increased | 259,153 | +27.6% | $145.7M | 0.8% | $560.05 | 53 |
| 2025-Q2 | Decreased | 203,057 | -2.1% | $106.6M | 0.6% | $519.56 | 0 |
| 2025-Q1 | Increased | 207,456 | +5.2% | $131.6M | 0.7% | $634.66 | 45 |
| 2024-Q4 | Increased | 197,266 | +25.1% | $140.5M | 0.7% | $698.71 | 52 |
| 2024-Q3 | Decreased | 157,740 | -3.4% | $165.8M | 0.7% | $1,036.94 | 0 |
| 2024-Q2 | Increased | 163,296 | +57.7% | $171.6M | 0.8% | $1,045.23 | 61 |